You just read:

Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Trial

News provided by

Alcyone Lifesciences, Inc.

Nov 26, 2018, 09:00 ET